Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Pulmonary Hypertension

  Free Subscription


19.01.2026

1 Adv Healthc Mater
1 Anesthesiology
2 Ann Card Anaesth
1 Blood Adv
1 BMC Anesthesiol
1 BMC Cardiovasc Disord
1 BMC Pulm Med
1 BMJ Case Rep
1 Cardiovasc Pathol
1 Cell Mol Biol Lett
1 Cell Physiol Biochem
1 Cell Signal
1 Chem Biol Drug Des
1 Chest
1 Clin Exp Rheumatol
1 Cureus
1 Echocardiography
2 Eur J Med Res
1 Eur Radiol
1 Eur Respir J
1 FP Essent
1 Hum Cell
1 Int J Biol Sci
1 Interv Cardiol
1 J Clin Invest
1 J Cutan Med Surg
1 J Ethnopharmacol
1 J Heart Lung Transplant
2 JHLT Open
1 Life Sci
1 Liver Transpl
1 Med Sci Monit
1 Pediatr Pulmonol
1 Pediatr Transplant
2 Pulm Circ
1 Quant Imaging Med Surg
1 Respir Med
2 Sci Rep
1 Sultan Qaboos Univ Med J
1 Zhonghua Xin Xue Guan Bing Za Zhi


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Healthc Mater

  1. YUE X, Lan J, Yang L, Zhao L, et al
    Curcumin-Loaded Tetrahedral Framework Nucleic Acids Alleviate Pulmonary Hypertension by Regulating Multiple Synergistic Signaling Pathways.
    Adv Healthc Mater. 2026 Jan 13:e05281. doi: 10.1002/adhm.202505281.
    PubMed         Abstract available


    Anesthesiology

  2. ZAZZERON L, Mereto E, Lichtenegger P, Moore E, et al
    Effects of continuous low-dose nitric oxide in a murine model of pulmonary hypertension with impaired lung development.
    Anesthesiology. 2026 Jan 16. doi: 10.1097/ALN.0000000000005939.
    PubMed         Abstract available


    Ann Card Anaesth

  3. CADD M
    Comment on "Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis".
    Ann Card Anaesth. 2026;29:150-151.
    PubMed        

  4. RASHID D, Zehra S
    Comment on "Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.
    Ann Card Anaesth. 2026;29:149-150.
    PubMed        


    Blood Adv

  5. LUCERO MJ, Setua S, Thangaraju K, Khan A, et al
    Ferroportin Inhibition Attenuates Pulmonary Hypertension in Hypoxic Sickle Cell Disease Mice.
    Blood Adv. 2026 Jan 15:bloodadvances.2025018680.
    PubMed         Abstract available


    BMC Anesthesiol

  6. ISHIHARA T, Kawamura G, Nagano M, Azuma S, et al
    Successful use of methylene blue for severe vasoplegia in a patient with partially-treated portopulmonary hypertension with atrial septal defect undergoing liver transplantation: a case report.
    BMC Anesthesiol. 2025;26:30.
    PubMed         Abstract available


    BMC Cardiovasc Disord

  7. LAKEW YB, Ahmed HY, Mulisa MD, Arega B, et al
    Prevalence of pulmonary hypertension and its associated factors among chronic kidney disease patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: an institution-based retrospective study.
    BMC Cardiovasc Disord. 2026 Jan 13. doi: 10.1186/s12872-026-05516.
    PubMed        


    BMC Pulm Med

  8. CETINKAYA C, Sagir A, Terzi A, Ermerak NO, et al
    Sclerotherapy embolism: a novel etiology for chronic thromboembolic pulmonary disease.
    BMC Pulm Med. 2025;26:14.
    PubMed         Abstract available


    BMJ Case Rep

  9. GIAKAS AM, Milano ME, Gehret JA, Rihn JA, et al
    Compressive cervicothoracolumbar epidural haematoma following lead insertion for spinal cord stimulator trial.
    BMJ Case Rep. 2026;19:e268333.
    PubMed         Abstract available


    Cardiovasc Pathol

  10. HUANG AP, Voskamp S, Ebadi AA, Liedel JL, et al
    Meta-analysis of differential gene expression in idiopathic pulmonary arterial hypertension.
    Cardiovasc Pathol. 2026;81:107805.
    PubMed         Abstract available


    Cell Mol Biol Lett

  11. WANG X, Li S, Hou J, Cao S, et al
    tsRNA-3040b accumulates R-loop to regulate Trim35 transcription, which leads to disordered glycolysis and promotes PAECs proliferation.
    Cell Mol Biol Lett. 2025;31:4.
    PubMed         Abstract available


    Cell Physiol Biochem

  12. ALIYAR AA, Eldar AS, Sadig SA, Mubariz GT, et al
    Advances in the Study of Bronchial and Vascular Architecture of Lungs in the Rat's Model: from Morphogenesis to Disease Modelling.
    Cell Physiol Biochem. 2025;59.
    PubMed         Abstract available


    Cell Signal

  13. CHEN J, Chen Y, Chen W, Tan Y, et al
    Set7 regulates ferroptosis in pulmonary arterial hypertension endothelial cells through the DPP4/NOX4 axis mediated by H3K4me1 modification.
    Cell Signal. 2026;139:112352.
    PubMed         Abstract available


    Chem Biol Drug Des

  14. ZHANG J, Zhang W, Fan B, Yang Z, et al
    Paeoniflorin Alleviates Pulmonary Arterial Hypertension by Suppressing TRIM24-Mediated SIRT1 Ubiquitination and NLRP3 Inflammasome Activation.
    Chem Biol Drug Des. 2026;107:e70238.
    PubMed         Abstract available


    Chest

  15. CELESTIN B, Bagherzadeh SP, Santana E, Frost M, et al
    Artificial Intelligence-Based Echocardiography in Pulmonary Arterial Hypertension.
    Chest. 2026;169:207-219.
    PubMed         Abstract available


    Clin Exp Rheumatol

  16. PINTO OLIVEIRA C, Pascoal MD, Prata AR, Carvalho D, et al
    Comment on: Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient.
    Clin Exp Rheumatol. 2026 Jan 12. doi: 10.55563.
    PubMed        


    Cureus

  17. SHARMA A, Bilal Y, Yousaf I, Masuta P, et al
    Pulmonary Hypertension in Rare Disease Overlap: Neurofibromatosis Type 1 Meets Sarcoidosis.
    Cureus. 2025;17:e98767.
    PubMed         Abstract available


    Echocardiography

  18. LI J, Han P, Zhao X, Lan L, et al
    Echocardiographic Analysis of Tricuspid Regurgitation and Other Hemodynamic Factors in Relation to Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Echocardiography. 2026;43:e70393.
    PubMed         Abstract available


    Eur J Med Res

  19. ZHAO L, Liu Y, Ou Z, Zhao X, et al
    GLP-1 agonists reduce right ventricular mitochondrial dysfunction by inhibiting the GSK3beta-Drp1 signalling in pulmonary hypertension.
    Eur J Med Res. 2026 Jan 10. doi: 10.1186/s40001-025-03815.
    PubMed         Abstract available

  20. CHEN X, Yan D, Liu C, Dai J, et al
    The trend analysis and comparison of pulmonary arterial hypertension disease burden in China and India from 1990 to 2021: a study based on the Global Burden of Disease 2021 database.
    Eur J Med Res. 2025;31:78.
    PubMed         Abstract available


    Eur Radiol

  21. LIU A, Du J, Li H, Xi L, et al
    What is the difference between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension on phase-resolved functional lung MRI? A cross-sectional observational study.
    Eur Radiol. 2026 Jan 13. doi: 10.1007/s00330-025-12271.
    PubMed         Abstract available


    Eur Respir J

  22. BACCELLI A, Haji G, Tighe H, Howard LS, et al
    Safety of Cardiopulmonary Exercise Testing in Pulmonary Hypertension: Insights from a UK Tertiary Referral Centre.
    Eur Respir J. 2026 Jan 15:2502207. doi: 10.1183/13993003.02207-2025.
    PubMed        


    FP Essent

  23. KAYSIN A, Swami S, Aluko O, Bultman DS, et al
    Topics in Lung Disease: Pulmonary Hypertension.
    FP Essent. 2025;559:7-15.
    PubMed         Abstract available


    Hum Cell

  24. ZHANG J, Fan Y, Gao Y, Jin Y, et al
    Histone deacetylase 3 promotes hypoxia-induced human pulmonary arterial smooth muscle cell proliferation by modulating the CSF2-JAK2-STAT5 signaling pathway.
    Hum Cell. 2026;39:35.
    PubMed         Abstract available


    Int J Biol Sci

  25. CHEN A, Yan Y, Cao R, Cai K, et al
    Zinc-Induced PKCdelta-dependent Phosphorylation of MTF-1 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension.
    Int J Biol Sci. 2026;22:823-840.
    PubMed         Abstract available


    Interv Cardiol

  26. BISCOTTI RODIL B, Duarte Torres J, Martin De Miguel I, Cruz Utrilla A, et al
    Chronic Thromboembolic Pulmonary Hypertension Incidence, Post-pulmonary Embolism Syndrome and Possible Role of Transcatheter Therapy in Prevention.
    Interv Cardiol. 2025;20:e37.
    PubMed         Abstract available


    J Clin Invest

  27. PRABHAKAR A, De Bie EM, DesJardin JT, Ghatpande P, et al
    GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.
    J Clin Invest. 2025;136:e199159.
    PubMed         Abstract available


    J Cutan Med Surg

  28. GUPTA S, Chopra D
    Do Nails Tell a Pulmonary Tale? A Cross-Sectional Study on Psoriasis and Pulmonary Hypertension Risk.
    J Cutan Med Surg. 2026 Jan 12:12034754251408375. doi: 10.1177/12034754251408375.
    PubMed         Abstract available


    J Ethnopharmacol

  29. LIU K, Peng W, Yang X, Zeng Y, et al
    Efficacy and Multi-Omics Regulatory Effects of Guilou Tongluo Formula in Patients with Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension: A Prospective, Multicenter, Randomized Controlled Trial.
    J Ethnopharmacol. 2026 Jan 12:121204. doi: 10.1016/j.jep.2026.121204.
    PubMed         Abstract available


    J Heart Lung Transplant

  30. DEWACHTER L, Vachiery JL
    Same Pressure, Different Disease: A Proteomic Rethinking of Pulmonary Hypertension in Chronic Lung Disease.
    J Heart Lung Transplant. 2026 Jan 13:S1053-2498(26)00008.
    PubMed        


    JHLT Open

  31. ZHANG P, Avazmohammadi R, Prins KW, Choudhary G, et al
    Mechano-energetic uncoupling in the right ventricle in pulmonary hypertension.
    JHLT Open. 2025;11:100460.
    PubMed         Abstract available

  32. GODINAS L, Orlitova M, Muscogiuri E, Ceulemans L, et al
    Lung transplantation for chronic thromboembolic pulmonary hypertension.
    JHLT Open. 2025;11:100461.
    PubMed         Abstract available


    Life Sci

  33. YANG Y, Zhang Y, Gong S, Liang N, et al
    Pulmonary neuroendocrine cell as a therapeutic strategy in pulmonary hypertension: Great expectations or Bleak House?
    Life Sci. 2026;388:124194.
    PubMed         Abstract available


    Liver Transpl

  34. DUBROCK HM, Savale L, Sitbon O, Raevens S, et al
    International Liver Transplantation Society practice guideline update on portopulmonary hypertension.
    Liver Transpl. 2026;32:296-314.
    PubMed         Abstract available


    Med Sci Monit

  35. LI Y, Xing H, Liu Y, Li F, et al
    Roles of the Altitude-Adapted Immune Microenvironment in Pulmonary Vascular Remodeling in High-Altitude Pulmonary Hypertension: A Review.
    Med Sci Monit. 2026;32:e949962.
    PubMed         Abstract available


    Pediatr Pulmonol

  36. TSOI SM, Parker C, Colglazier E, Cheung S, et al
    The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension.
    Pediatr Pulmonol. 2026;61:e71448.
    PubMed         Abstract available


    Pediatr Transplant

  37. KLOUDA T, Wong W, Fynn-Thompson F, Esch JJ, et al
    Lung Transplantation and Reverse Potts Shunt for Pulmonary Hypertension in the Pediatric Population.
    Pediatr Transplant. 2026;30:e70263.
    PubMed         Abstract available


    Pulm Circ

  38. ZHAO Y, Wang J, Qiao Y, Gai X, et al
    Echinacoside Improves Pulmonary Vascular Remodeling by Regulating the L- and T-Type Ca(2+) Channels in the Prevention and Treatment of Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70235.
    PubMed         Abstract available

  39. MENDES-FERREIRA P, Tielemans B, Wagenaar A, Bouzin C, et al
    Beta-3 Adrenoreceptor Agonist Mirabegron Improves Right Ventricular Function in a Rat Monocrotaline-Induced Pulmonary Hypertension Model.
    Pulm Circ. 2026;16:e70232.
    PubMed         Abstract available


    Quant Imaging Med Surg

  40. YUAN W, Tie H, Feng T, Zhang F, et al
    Successful surgical intervention for Berry syndrome combined with severe pulmonary hypertension: a case description.
    Quant Imaging Med Surg. 2026;16:100.
    PubMed        


    Respir Med

  41. HERRERA-LEANO N, Sahay S, Benza RL, Barahona-Correa J, et al
    Old Criteria, New Intelligence: The Evolution of ECG in Pulmonary Hypertension Diagnosis.
    Respir Med. 2026 Jan 14:108646. doi: 10.1016/j.rmed.2026.108646.
    PubMed         Abstract available


    Sci Rep

  42. ZHU Y, Wang X, Yan X, Sun Y, et al
    Identification of potential biomarkers associated with mitochondrial oxidative stress in idiopathic pulmonary arterial hypertension via bioinformatic and experimental analysis.
    Sci Rep. 2025;16:1647.
    PubMed         Abstract available

  43. MOU H, Zhang G, Xiu L, Zhao Q, et al
    AI-assisted multimodal assessment for right ventricular function from echocardiography predicts mortality in patients with pulmonary hypertension and right heart failure.
    Sci Rep. 2026 Jan 16. doi: 10.1038/s41598-026-36533.
    PubMed         Abstract available


    Sultan Qaboos Univ Med J

  44. ABOLWAFA A, Al-Lawati A, Al-Kindi HN, Zacharias S, et al
    Surgical Strategies for Unilateral Pulmonary Artery Agenesis: A case series.
    Sultan Qaboos Univ Med J. 2025;26:13-19.
    PubMed         Abstract available


    Zhonghua Xin Xue Guan Bing Za Zhi


  45. [Guidelines for the diagnosis and treatment of pulmonary arterial hypertension associated with adult congenital heart disease].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2026;54:9-38.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.